UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
| Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | |
| For the quarterly period ended November 2, 2002 or | |
| Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | |
| For the transition period from to |
Commission File Number 1-4311
PALL
CORPORATION
(Exact name of registrant as specified
in its charter)
New
York
(State or other jurisdiction
of incorporation or organization) |
11-1541330 (I.R.S. Employer Identification No.) |
|
| 2200 Northern Boulevard, East Hills,
NY (Address of principal executive offices) |
11548 (Zip Code) |
|
| (516) 4845400 (Registrants telephone number, including area code) |
||
Indicate by check mark whether the registrant (1) has
filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter
period that registrant was required to file such reports), and (2) has
been subject to such filing requirement for the past 90 days. Yes
No
The number of shares of the registrant’s common stock outstanding as of December 6, 2002 was 122,973,348.
TABLE OF CONTENTS
Page
No. |
||
| PART I. | FINANCIAL INFORMATION | |
| Item 1. | Financial Statements | |
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations. | 13 |
| Item 4. | Controls and Procedures | 18 |
| PART II. | OTHER INFORMATION | |
| Item 1. | Legal Proceedings. | 18 |
| Item 6. | Exhibits and Reports on Form 8-K. | 19 |
| SIGNATURES | 20 |
2
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
PALL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)
(Unaudited)
| Nov. 2, 2002 | Aug. 3, 2002 | |||||
|
|
|
|
|
|||
|
ASSETS |
||||||
| Current assets: | ||||||
|
Cash
and cash equivalents |
$ | 90,507 | $ | 105,224 | ||
|
Short-term
investments |
22,600 | 40,200 | ||||
|
Accounts
receivable, net |
364,293 | 415,853 | ||||
|
Inventories
|
279,832 | 256,910 | ||||
|
Other
current assets |
82,111 | 97,795 | ||||
|
|
|
|
|
|||
|
Total
current assets |
839,343 | 915,982 | ||||
| Property, plant and equipment, net | 599,587 | 605,095 | ||||
| Goodwill, net | 226,101 | 262,973 | ||||
| Intangible assets, net | 55,338 | 39,948 | ||||
| Other assets | 194,850 | 203,224 | ||||
|
|
|
|
|
|||
|
Total
assets |
$ | 1,915,219 | $ | 2,027,222 | ||
|
|
|
|
|
|||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||
| Current liabilities: | ||||||
|
Notes
payable to banks |
$ | 14,095 | $ | 42,202 | ||
|
Accounts
payable and other current liabilities |
264,384 | 293,076 | ||||
|
Income
taxes |
29,471 | 41,549 | ||||
|
Current
portion of long-term debt |
56,656 | 61,344 | ||||
|
|
|
|
|
|||
|
Total
current liabilities |
364,606 | 438,171 | ||||
| Long-term debt, net of current portion | 617,904 | 619,705 | ||||
| Deferred taxes and other non-current liabilities | 144,628 | 149,626 | ||||
|
|
|
|
|
|||
|
Total
liabilities |
1,127,138 | 1,207,502 | ||||
|
|
|
|
|
|||
| Stockholders’ equity: | ||||||
|
Common
stock, par value $.10 per share |
12,796 | 12,796 | ||||
|
Capital
in excess of par value |
110,409 | 110,745 | ||||
|
Retained
earnings |
797,954 | 832,308 | ||||
|
Treasury
stock, at cost |
(109,773 | ) | (110,799 | ) | ||
|
Stock
option loans |
(2,695 | ) | (3,259 | ) | ||
|
Accumulated
other comprehensive loss: |
||||||
|
Foreign
currency translation |
(13,768 | ) | (17,429 | ) | ||
|
Minimum
pension liability |
(3,075 | ) | (3,079 | ) | ||
|
Unrealized
investment losses |
(2,705 | ) | (236 | ) | ||
|
Unrealized
losses on derivatives |
(1,062 | ) | (1,327 | ) | ||
|
|
|
|
|
|||
| (20,610 | ) | (22,071 | ) | |||
|
|
|
|
|
|||
| Total stockholders’ equity | 788,081 | 819,720 | ||||
|
|
|
|
|
|||
| Total liabilities and stockholders’ equity | $ | 1,915,219 | $ | 2,027,222 | ||
|
|
|
|
|
See accompanying notes to condensed consolidated financial statements.
3
PALL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS
OF OPERATIONS
(In thousands, except per share data)
(Unaudited)
| Three Months Ended | ||||||
| Nov. 2, 2002 | Oct. 27, 2001 | |||||
| Net sales | $ | 332,210 | $ | 274,119 | ||
| Cost of sales | 174,261 | 135,070 | ||||
| Gross profit | 157,949 | 139,049 | ||||
| Selling, general and administrative expenses | 116,860 | 98,074 | ||||
| Research and development | 13,045 | 12,847 | ||||
| Restructuring and other charges | 40,375 | | ||||
| Interest expense, net | 7,266 | 3,263 | ||||
| (Loss) earnings before income taxes | (19,597 | ) | 24,865 | |||
| Income taxes | 3,541 | 5,473 | ||||
| Net (loss) earnings | $ | (23,138 | ) | $ | 19,392 | |
| (Loss) earnings per share: | ||||||
Basic
|
$ | (0.19 | ) | $ | 0.16 | |
Diluted
|
$ | (0.19 | ) | $ | 0.16 | |
| Dividends declared per share | $ | 0.09 | $ | 0.17 | ||
| Average shares outstanding: | ||||||
Basic
|
122,825 | 122,190 | ||||
Diluted
|
122,825 | 123,486 | ||||
See accompanying notes to condensed consolidated financial statements.
4
PALL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS
OF CASH FLOWS
(In thousands)
(Unaudited)
| Three Months Ended | ||||||
|
|
|
|||||
| Nov. 2, 2002 | Oct. 27, 2001 | |||||
|
|
|
|
|
|||
| Net cash provided by operating activities, net of effect of acquisitions | $ | 34,795 | $ | 16,614 | ||
| Investing activities: | ||||||
| Acquisitions of businesses | (7,999 | ) | | |||
| Capital expenditures | (14,456 | ) | (19,374 | ) | ||
| Disposals of fixed assets | 1,118 | 595 | ||||
| Short-term investments | 17,600 | 71,400 | ||||
|
|
|
|
|
|||
| Net cash (used) provided by investing activities | (3,737 | ) | 52,621 | |||
|
|
|
|
|
|||
| Financing activities: | ||||||
| Notes payable | (379,099 | ) | (14,786 | ) | ||
| Long-term borrowings | 380,004 | 1,497 | ||||
| Repayments of long-term debt | (37,236 | ) | (31,711 | ) | ||
| Net proceeds from stock plans | 1,148 | 3,192 | ||||
| Purchase of treasury stock | | (9,999 | ) | |||
| Dividends paid | (11,049 | ) | (20,808 | ) | ||
|
|
|
|
|
|||
| Net cash used by financing activities | (46,232 | ) | (72,615 | ) | ||
|
|
|
|
|
|||
| Cash flow for period | (15,174 | ) | (3,380 | ) | ||
| Cash and cash equivalents at beginning of year | 105,224 | 54,927 | ||||
| Effect of exchange rate changes on cash | 457 | 172 | ||||
|
|
|
|
|
|||
| Cash and cash equivalents at end of period | $ | 90,507 | $ | 51,719 | ||
|
|
|
|
|
|||
| Supplemental disclosures: | ||||||
|
Interest
paid |
$ | 5,125 | $ | 7,511 | ||
|
Income
taxes paid (net of refunds) |
8,234 | 11,103 | ||||
See accompanying notes to condensed consolidated financial statements.
5
PALL CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except per share data)
(Unaudited)
NOTE 1 BASIS OF PRESENTATION
The financial information included herein is unaudited. However, such information reflects all adjustments which are, in the opinion of management, necessary to present fairly the Company’s financial position, results of operations and cash flows as of the dates and for the periods presented herein. These financial statements should be read in conjunction with the financial statements and notes set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended August 3, 2002.
NOTE 2 ACQUISITION
On April 24, 2002, the Company acquired the Filtration and Separations Group (“FSG”) from United States Filter Corporation (“US Filter”) for $360,000 in cash, subject to a post closing adjustment of the purchase price based on the net assets acquired as of April 27, 2002. The adjustment to the purchase price was finalized in the first quarter of fiscal 2003, resulting in additional consideration due to US Filter of $7,801. The operating results of FSG are reported in the Company’s results of operations from April 28, 2002.
The acquisition was accounted for using the purchase method of accounting in accordance with SFAS No. 141, Business Combinations (“SFAS No. 141”). SFAS No. 141 requires that the total cost of the acquisition be allocated to the tangible and intangible assets acquired and liabilities assumed based upon their respective fair values at the date of acquisition. The allocation of the purchase price is dependent upon certain valuations and other studies. In the first quarter of fiscal 2003, the valuation of in-process research and development and certain amortizable intangible assets, patented and unpatented technology, was finalized. As a result, the Company wrote-off $37,600 of preliminary goodwill as in-process research and development and reallocated $16,800 of preliminary goodwill to write up the aforementioned amortizable intangible assets from their book value to their fair value of $20,100 (please refer to Note 3 for further discussion). The amount of in-process research and development was determined by identifying research projects for which technological feasibility had not been established and for which no alternative future uses existed. As of the acquisition date, there were various projects that met the above criteria. The majority of the projects identified are targeted for the General Industrial segment.
The value of the research projects identified to be in process was determined by estimating the future cash flows from the projects once commercially feasible, discounting the net cash flows back to their present value and then applying a percentage of completion to the calculated value. The key assumptions specifically underlying the valuation for purchased in-process research and development consist of an expected completion date for the in-process projects, estimated costs to complete the projects, revenue and expense projections, and discount rates based on the risks associated with the development life cycle of the in-process technology acquired. The weighted average discount rate used was approximately 24% (ranging from 18% to 67%). The percentage of completion for the projects was determined using milestones representing estimates of effort, value added and degree of difficulty of the portion of the projects completed as of April 27, 2002, as compared to the total research and development to be completed to bring the projects to technological feasibility. As of April 27, 2002, the Company estimates the projects were approximately 67% complete on a weighted average basis (ranging from 2% to 96%).
The development of these technologies remains an uncertainty due to the remaining efforts to achieve technological feasibility, changing customer markets, and significant competitive threats from other companies.
At the date of acquisition, management began formulating integration plans which contemplate the closure of redundant facilities and the sale of certain businesses. In addition, the synergies created by joining the two organizations have resulted in employee terminations. The condensed consolidated balance sheet at November 2, 2002 reflects liabilities for such items; however, we will continue to finalize and announce other integration plans during fiscal 2003. The finalization of these integration plans concerning FSG’s facilities and employees will be reported in future periods as increases and decreases to goodwill and to the assets acquired and liabilities assumed. The November 2, 2002 condensed consolidated balance sheet reflects the preliminary allocation of the purchase price and goodwill of $170,109. The financial statement impact of integration plans that concern Pall facilities and employees will be reflected in earnings. Refer to Note 3 for discussion of actions taken in the first quarter of fiscal 2003. The goodwill related to the FSG acquisition is not tax deductible.
6
PALL CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(In thousands, except per share data)
(Unaudited)
The following table summarizes the preliminary allocation of the purchase price to the assets acquired and liabilities assumed:
| Purchase price | $ | 367,801 | |
| Transaction costs | 7,033 | ||
| Total cost | 374,834 | ||
| Cash acquired | 19,671 | ||
| Total purchase price, net of cash acquired | 355,163 | ||
| Current assets | 164,453 | ||
| Property, plant and equipment | 91,128 | ||
| Intangible assets | 23,617 | ||
| Other non-current assets | 3,900 | ||
| In-process research and development | 37,600 | ||
| Total assets and in-process research and development acquired | 320,698 | ||
| Current liabilities | 101,144 | ||
| Non-current liabilities | 34,500 | ||
| Total liabilities assumed | 135,644 | ||
| Goodwill | $ | 170,109 | |
Goodwill has been allocated preliminarily to the Company’s reportable segments as follows:
| BioPharmaceuticals | $ | 12,911 | |
| General Industrial | 136,121 | ||
| Microelectronics | 21,077 | ||
| Total | $ | 170,109 | |
NOTE 3 RESTRUCTURING AND OTHER CHARGES
The following table summarizes the restructuring related items and other charges recorded in the first quarter of fiscal 2003:
| Restructuring | Other Charges and Adjustments |
Total Charged To Earnings |
Adjustments to Goodwill (a) |
Total | |||||||||||
| In-process research and development (b) | $ | | $ | 37,600 |
$ | 37,600 |
$ | |
$ | 37,600 |
|||||
| Severance (c) | 2,775 | | 2,775 | 2,114 | 4,889 | ||||||||||
| Fixed asset write-offs (c) | | | | 451 | 451 | ||||||||||
| Office closures (c) | | | | 1,267 | 1,267 | ||||||||||
| Other (c) | | | | 487 | 487 | ||||||||||
| Total | $ | 2,775 | $ | 37,600 | $ | 40,375 | $ | 4,319 | $ | 44,694 | |||||
|
|
|
|
|
|
|||||||||||
| Cash | $ | 2,775 | $ | | $ | 2,775 | $ | 3,868 | $ | 6,643 | |||||
| Non-cash | | 37,600 | 37,600 | 451 | 38,051 | ||||||||||
| Total | $ | 2,775 | $ | 37,600 | $ | 40,375 | $ | 4,319 | $ | 44,694 | |||||
| (a) | Reflects restructuring activities related to FSG employees and facilities (refer to Note 2 for discussion of purchase accounting). |
| (b) | In the first quarter of fiscal 2003, the Company recorded a charge of $37,600 for in-process research and development acquired in the acquisition of FSG. Please also refer to Note 2 for further discussion. |
| (c) | At the date of the FSG acquisition, management began formulating integration plans and identifying synergistic opportunities. During the fourth quarter of fiscal 2002 and in the first quarter of fiscal 2003, the Company announced and implemented plans to eliminate redundant employees and facilities. |
7
PALL CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (continued)
(In thousands, except per share data)
(Unaudited)
| Furthermore, during the first quarter of fiscal 2003, the Company reorganized its Life Sciences business such that the Company’s hospital and medical OEM sub-segments were combined with the Blood segment to form a new segment called Pall Medical. Please refer to Note 8 for further information. This reorganization is expected to reduce costs and has resulted in the termination of employees globally. | |
| These actions resulted in the recording of approximately $4,889 in severance related liabilities for an estimated workforce reduction of 105 people, of which approximately 70 employees had been terminated in the first quarter of fiscal 2003. In addition, liabilities of approximately $1,754 were recorded principally for lease termination and other office closure costs. Fixed asset write-offs amounted to approximately $451 in the first quarter of fiscal 2003. | |
| Cash requirements of these actions are expected to be $6,643 of which $2,503 has been expended, leaving $4,140 in accruals reflected on the balance sheet as of November 2, 2002. The expected cash outlays comprise $4,889 in employee termination benefits and $1,754 principally related to lease termination liabilities and other office closure costs |
The following table summarizes the activity in the first quarter of fiscal 2003 affecting the reserve balances related to restructuring actions taken in fiscal 2002 and fiscal 2003:
| Restructuring
liabilities recorded in: |
|||||||||
| Fiscal 2003 | Fiscal 2002 | Total | |||||||
Balance
at August 3, 2002 |
$ | | $ | 10,424 | $ | 10,424 | |||
Current
year additions |
6,643 | | 6,643 | ||||||
Utilized |
(2,503 | ) | (6,101 | ) | (8,604 | ) | |||
Balance
at November 2, 2002 |
$ | 4,140 | $ | 4,323 | $ | 8,463 | |||
NOTE 4 BALANCE SHEET DETAILS
The following tables provide details of selected balance sheet items:
| Nov. 2, 2002 | Aug. 3, 2002 | |||||
|
|
|
|
|
|||
|
Accounts
receivable, net: |
||||||
|
Accounts
receivable |
$ | 377,328 | $ | 428,759 | ||
|
Less:
Allowances for doubtful accounts |
13,035 | 12,906 | ||||
|
|
|
|
|
|||
|
Total
|
$ | 364,293 | $ | 415,853 | ||
|
|
|
|
|
|||
|
Inventories: |
||||||
|
Raw
materials and components |
$ | 92,148 | $ | 90,807 | ||
|
Work-in-process
|
45,392 | 40,323 | ||||
|
Finished
goods |
142,292 | 125,780 | ||||
|
|
|
|
|
|||
|
Total
|
$ | 279,832 | $ | 256,910 | ||
|
|
|
|
|
|||
|
Property,
plant and equipment, net: |
||||||
|
Property,
plant and equipment |
$ | 1,134,093 | $ | 1,125,174 | ||
|
Less:
Accumulated depreciation and amortization |
534,506 | 520,079 | ||||
|
|
|
|
|
|||
|
Total
|
$ | 599,587 | $ | 605,095 | ||
|
|
|
|
|
8
PALL CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (continued)
(In thousands, except per share data)
(Unaudited)
NOTE 5 NOTES PAYABLE AND LONG-TERM DEBT
On August 6, 2002, the Company completed an offering of $280,000 of 6% senior notes due on August 1, 2012. The notes are unsecured and unsubordinated obligations of the Company and rank pari passu to its other outstanding unsecured and unsubordinated indebtedness. On October 18, 2002, the Company entered into a $100,000 LIBOR based variable rate bank loan, which matures in quarterly installments of $5,000 starting in January 2003 through October 2007. The proceeds of the notes and loan were used to repay the interim credit facility taken to finance the FSG acquisition and for general corporate purposes.
On November 26, 2002, the Company terminated “receive fixed, pay variable” interest rate swaps relating to its $100,000 private placement of 7.83% unsecured senior notes due in 2010 and as a result the Company received $8,568. Simultaneously, the Company entered into new interest rate swaps involving the $280,000, 6% notes due on August 1, 2012. The new swaps require the Company to make payments at a variable rate based on LIBOR and receive payments at a fixed rate of 6% on notional amounts totaling $230,000.
NOTE 6 GOODWILL AND INTANGIBLE ASSETS
The following table presents goodwill, net of accumulated amortization prior to the adoption of SFAS No. 142, allocated by reportable segment solely for purposes of SFAS No. 142 disclosure as of November 2, 2002 and August 3, 2002:
| Nov. 2, 2002 | Aug. 3, 2002 | |||||
| Medical | $ | 20,253 | $ | 19,512 | ||
| BioPharmaceuticals | 27,866 | 31,423 | ||||
| Life Sciences | 48,119 | 50,935 | ||||
| General Industrial | 150,646 | 180,356 | ||||
| Aerospace | 6,122 | 6,038 | ||||
| Microelectronics | 21,214 | 25,644 | ||||
| Industrial | 177,982 | 212,038 | ||||
| Total | $ | 226,101 | $ | 262,973 | ||
The change in the carrying amount of goodwill is primarily attributable to the changes in the preliminary allocation of goodwill from the acquisition of FSG and to the translation of goodwill contained in the financial statements of foreign subsidiaries using the rates at each respective balance sheet date.
Intangible assets, net, consist of the following:
| Nov. 2, 2002 | Aug. 3, 2002 | |||||
| Patents and unpatented technology | $ | 78,167 | $ | 60,381 | ||
| Trademarks and other | 9,363 | 9,605 | ||||
| Subtotal | 87,530 | 69,986 | ||||
| Less: Accumulated amortization | 32,192 | 30,038 | ||||
| Total | $ | 55,338 | $ | 39,948 | ||
Patents and trademarks include costs to register new patents and trademarks. Patents also include expenditures to successfully defend certain patents as well as for paid-up licenses for third-party patents. The increase in patents and unpatented technology is due to the finalization, in the first quarter of fiscal 2003, of the valuation of intangible assets purchased in the FSG acquisition. The fair values of these intangibles had not been determined as of August 3, 2002; as such, their cost had been preliminarily allocated based upon their book values.
Amortization expense for these intangible assets for the three months ended November 2, 2002 and October 27, 2001 was $1,957 and $1,194, respectively. Amortization expense is estimated to be approximately $5,623 for the remainder of fiscal 2003 and $7,300 in 2004, $5,600 in 2005 and $5,100 in 2006, 2007 and in 2008.
9
PALL CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (continued)